Individualized resuscitation strategy for septic shock formalized by finite mixture modeling and dynamic treatment regimen

Background Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class. Methods Patients with...

Full description

Saved in:
Bibliographic Details
Published inCritical care (London, England) Vol. 25; no. 1; pp. 1 - 16
Main Authors Ma, Penglin, Liu, Jingtao, Shen, Feng, Liao, Xuelian, Xiu, Ming, Zhao, Heling, Zhao, Mingyan, Xie, Jing, Wang, Peng, Huang, Man, Li, Tong, Duan, Meili, Qian, Kejian, Peng, Yue, Zhou, Feihu, Xin, Xin, Wan, Xianyao, Wang, ZongYu, Li, Shusheng, Han, Jianwei, Li, Zhenliang, Ding, Guolei, Deng, Qun, Zhang, Jicheng, Zhu, Yue, Ma, Wenjing, Wang, Jingwen, Kang, Yan, Zhang, Zhongheng
Format Journal Article
LanguageEnglish
Published London BioMed Central Ltd 12.07.2021
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class. Methods Patients with septic shock in 25 tertiary care teaching hospitals in China from January 2016 to December 2017 were enrolled in the study. Clinical and laboratory variables were collected on days 0, 1, 2, 3 and 7 after ICU admission. Subclasses of septic shock were identified by both finite mixture modeling and K-means clustering. Individualized fluid volume and norepinephrine dose were estimated using dynamic treatment regime (DTR) model to optimize the final mortality outcome. DTR models were validated in the eICU Collaborative Research Database (eICU-CRD) dataset. Results A total of 1437 patients with a mortality rate of 29% were included for analysis. The finite mixture modeling and K-means clustering robustly identified five classes of septic shock. Class 1 (baseline class) accounted for the majority of patients over all days; class 2 (critical class) had the highest severity of illness; class 3 (renal dysfunction) was characterized by renal dysfunction; class 4 (respiratory failure class) was characterized by respiratory failure; and class 5 (mild class) was characterized by the lowest mortality rate (21%). The optimal fluid infusion followed the resuscitation/de-resuscitation phases with initial large volume infusion and late restricted volume infusion. While class 1 transitioned to de-resuscitation phase on day 3, class 3 transitioned on day 1. Classes 1 and 3 might benefit from early use of norepinephrine, and class 2 can benefit from delayed use of norepinephrine while waiting for adequate fluid infusion. Conclusions Septic shock comprises a heterogeneous population that can be robustly classified into five phenotypes. These classes can be easily identified with routine clinical variables and can help to tailor resuscitation strategy in the context of precise medicine. Keywords: Sepsis, Dynamic treatment regime, Mortality, Fluid resuscitation
AbstractList Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class.BACKGROUNDSeptic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class.Patients with septic shock in 25 tertiary care teaching hospitals in China from January 2016 to December 2017 were enrolled in the study. Clinical and laboratory variables were collected on days 0, 1, 2, 3 and 7 after ICU admission. Subclasses of septic shock were identified by both finite mixture modeling and K-means clustering. Individualized fluid volume and norepinephrine dose were estimated using dynamic treatment regime (DTR) model to optimize the final mortality outcome. DTR models were validated in the eICU Collaborative Research Database (eICU-CRD) dataset.METHODSPatients with septic shock in 25 tertiary care teaching hospitals in China from January 2016 to December 2017 were enrolled in the study. Clinical and laboratory variables were collected on days 0, 1, 2, 3 and 7 after ICU admission. Subclasses of septic shock were identified by both finite mixture modeling and K-means clustering. Individualized fluid volume and norepinephrine dose were estimated using dynamic treatment regime (DTR) model to optimize the final mortality outcome. DTR models were validated in the eICU Collaborative Research Database (eICU-CRD) dataset.A total of 1437 patients with a mortality rate of 29% were included for analysis. The finite mixture modeling and K-means clustering robustly identified five classes of septic shock. Class 1 (baseline class) accounted for the majority of patients over all days; class 2 (critical class) had the highest severity of illness; class 3 (renal dysfunction) was characterized by renal dysfunction; class 4 (respiratory failure class) was characterized by respiratory failure; and class 5 (mild class) was characterized by the lowest mortality rate (21%). The optimal fluid infusion followed the resuscitation/de-resuscitation phases with initial large volume infusion and late restricted volume infusion. While class 1 transitioned to de-resuscitation phase on day 3, class 3 transitioned on day 1. Classes 1 and 3 might benefit from early use of norepinephrine, and class 2 can benefit from delayed use of norepinephrine while waiting for adequate fluid infusion.RESULTSA total of 1437 patients with a mortality rate of 29% were included for analysis. The finite mixture modeling and K-means clustering robustly identified five classes of septic shock. Class 1 (baseline class) accounted for the majority of patients over all days; class 2 (critical class) had the highest severity of illness; class 3 (renal dysfunction) was characterized by renal dysfunction; class 4 (respiratory failure class) was characterized by respiratory failure; and class 5 (mild class) was characterized by the lowest mortality rate (21%). The optimal fluid infusion followed the resuscitation/de-resuscitation phases with initial large volume infusion and late restricted volume infusion. While class 1 transitioned to de-resuscitation phase on day 3, class 3 transitioned on day 1. Classes 1 and 3 might benefit from early use of norepinephrine, and class 2 can benefit from delayed use of norepinephrine while waiting for adequate fluid infusion.Septic shock comprises a heterogeneous population that can be robustly classified into five phenotypes. These classes can be easily identified with routine clinical variables and can help to tailor resuscitation strategy in the context of precise medicine.CONCLUSIONSSeptic shock comprises a heterogeneous population that can be robustly classified into five phenotypes. These classes can be easily identified with routine clinical variables and can help to tailor resuscitation strategy in the context of precise medicine.
Background Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class. Methods Patients with septic shock in 25 tertiary care teaching hospitals in China from January 2016 to December 2017 were enrolled in the study. Clinical and laboratory variables were collected on days 0, 1, 2, 3 and 7 after ICU admission. Subclasses of septic shock were identified by both finite mixture modeling and K-means clustering. Individualized fluid volume and norepinephrine dose were estimated using dynamic treatment regime (DTR) model to optimize the final mortality outcome. DTR models were validated in the eICU Collaborative Research Database (eICU-CRD) dataset. Results A total of 1437 patients with a mortality rate of 29% were included for analysis. The finite mixture modeling and K-means clustering robustly identified five classes of septic shock. Class 1 (baseline class) accounted for the majority of patients over all days; class 2 (critical class) had the highest severity of illness; class 3 (renal dysfunction) was characterized by renal dysfunction; class 4 (respiratory failure class) was characterized by respiratory failure; and class 5 (mild class) was characterized by the lowest mortality rate (21%). The optimal fluid infusion followed the resuscitation/de-resuscitation phases with initial large volume infusion and late restricted volume infusion. While class 1 transitioned to de-resuscitation phase on day 3, class 3 transitioned on day 1. Classes 1 and 3 might benefit from early use of norepinephrine, and class 2 can benefit from delayed use of norepinephrine while waiting for adequate fluid infusion. Conclusions Septic shock comprises a heterogeneous population that can be robustly classified into five phenotypes. These classes can be easily identified with routine clinical variables and can help to tailor resuscitation strategy in the context of precise medicine.
Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class. A total of 1437 patients with a mortality rate of 29% were included for analysis. The finite mixture modeling and K-means clustering robustly identified five classes of septic shock. Class 1 (baseline class) accounted for the majority of patients over all days; class 2 (critical class) had the highest severity of illness; class 3 (renal dysfunction) was characterized by renal dysfunction; class 4 (respiratory failure class) was characterized by respiratory failure; and class 5 (mild class) was characterized by the lowest mortality rate (21%). The optimal fluid infusion followed the resuscitation/de-resuscitation phases with initial large volume infusion and late restricted volume infusion. While class 1 transitioned to de-resuscitation phase on day 3, class 3 transitioned on day 1. Classes 1 and 3 might benefit from early use of norepinephrine, and class 2 can benefit from delayed use of norepinephrine while waiting for adequate fluid infusion. Septic shock comprises a heterogeneous population that can be robustly classified into five phenotypes. These classes can be easily identified with routine clinical variables and can help to tailor resuscitation strategy in the context of precise medicine.
Background Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class. Methods Patients with septic shock in 25 tertiary care teaching hospitals in China from January 2016 to December 2017 were enrolled in the study. Clinical and laboratory variables were collected on days 0, 1, 2, 3 and 7 after ICU admission. Subclasses of septic shock were identified by both finite mixture modeling and K-means clustering. Individualized fluid volume and norepinephrine dose were estimated using dynamic treatment regime (DTR) model to optimize the final mortality outcome. DTR models were validated in the eICU Collaborative Research Database (eICU-CRD) dataset. Results A total of 1437 patients with a mortality rate of 29% were included for analysis. The finite mixture modeling and K-means clustering robustly identified five classes of septic shock. Class 1 (baseline class) accounted for the majority of patients over all days; class 2 (critical class) had the highest severity of illness; class 3 (renal dysfunction) was characterized by renal dysfunction; class 4 (respiratory failure class) was characterized by respiratory failure; and class 5 (mild class) was characterized by the lowest mortality rate (21%). The optimal fluid infusion followed the resuscitation/de-resuscitation phases with initial large volume infusion and late restricted volume infusion. While class 1 transitioned to de-resuscitation phase on day 3, class 3 transitioned on day 1. Classes 1 and 3 might benefit from early use of norepinephrine, and class 2 can benefit from delayed use of norepinephrine while waiting for adequate fluid infusion. Conclusions Septic shock comprises a heterogeneous population that can be robustly classified into five phenotypes. These classes can be easily identified with routine clinical variables and can help to tailor resuscitation strategy in the context of precise medicine. Keywords: Sepsis, Dynamic treatment regime, Mortality, Fluid resuscitation
Abstract Background Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class. Methods Patients with septic shock in 25 tertiary care teaching hospitals in China from January 2016 to December 2017 were enrolled in the study. Clinical and laboratory variables were collected on days 0, 1, 2, 3 and 7 after ICU admission. Subclasses of septic shock were identified by both finite mixture modeling and K-means clustering. Individualized fluid volume and norepinephrine dose were estimated using dynamic treatment regime (DTR) model to optimize the final mortality outcome. DTR models were validated in the eICU Collaborative Research Database (eICU-CRD) dataset. Results A total of 1437 patients with a mortality rate of 29% were included for analysis. The finite mixture modeling and K-means clustering robustly identified five classes of septic shock. Class 1 (baseline class) accounted for the majority of patients over all days; class 2 (critical class) had the highest severity of illness; class 3 (renal dysfunction) was characterized by renal dysfunction; class 4 (respiratory failure class) was characterized by respiratory failure; and class 5 (mild class) was characterized by the lowest mortality rate (21%). The optimal fluid infusion followed the resuscitation/de-resuscitation phases with initial large volume infusion and late restricted volume infusion. While class 1 transitioned to de-resuscitation phase on day 3, class 3 transitioned on day 1. Classes 1 and 3 might benefit from early use of norepinephrine, and class 2 can benefit from delayed use of norepinephrine while waiting for adequate fluid infusion. Conclusions Septic shock comprises a heterogeneous population that can be robustly classified into five phenotypes. These classes can be easily identified with routine clinical variables and can help to tailor resuscitation strategy in the context of precise medicine.
ArticleNumber 243
Audience Academic
Author Zhang, Jicheng
Peng, Yue
Li, Zhenliang
Duan, Meili
Zhou, Feihu
Kang, Yan
Qian, Kejian
Ma, Penglin
Liao, Xuelian
Ma, Wenjing
Wang, Jingwen
Wang, ZongYu
Han, Jianwei
Wang, Peng
Liu, Jingtao
Li, Tong
Xin, Xin
Wan, Xianyao
Deng, Qun
Zhao, Mingyan
Shen, Feng
Xie, Jing
Zhao, Heling
Huang, Man
Zhang, Zhongheng
Li, Shusheng
Xiu, Ming
Zhu, Yue
Ding, Guolei
Author_xml – sequence: 1
  givenname: Penglin
  surname: Ma
  fullname: Ma, Penglin
– sequence: 2
  givenname: Jingtao
  surname: Liu
  fullname: Liu, Jingtao
– sequence: 3
  givenname: Feng
  surname: Shen
  fullname: Shen, Feng
– sequence: 4
  givenname: Xuelian
  surname: Liao
  fullname: Liao, Xuelian
– sequence: 5
  givenname: Ming
  surname: Xiu
  fullname: Xiu, Ming
– sequence: 6
  givenname: Heling
  surname: Zhao
  fullname: Zhao, Heling
– sequence: 7
  givenname: Mingyan
  surname: Zhao
  fullname: Zhao, Mingyan
– sequence: 8
  givenname: Jing
  surname: Xie
  fullname: Xie, Jing
– sequence: 9
  givenname: Peng
  surname: Wang
  fullname: Wang, Peng
– sequence: 10
  givenname: Man
  surname: Huang
  fullname: Huang, Man
– sequence: 11
  givenname: Tong
  surname: Li
  fullname: Li, Tong
– sequence: 12
  givenname: Meili
  surname: Duan
  fullname: Duan, Meili
– sequence: 13
  givenname: Kejian
  surname: Qian
  fullname: Qian, Kejian
– sequence: 14
  givenname: Yue
  surname: Peng
  fullname: Peng, Yue
– sequence: 15
  givenname: Feihu
  surname: Zhou
  fullname: Zhou, Feihu
– sequence: 16
  givenname: Xin
  surname: Xin
  fullname: Xin, Xin
– sequence: 17
  givenname: Xianyao
  surname: Wan
  fullname: Wan, Xianyao
– sequence: 18
  givenname: ZongYu
  surname: Wang
  fullname: Wang, ZongYu
– sequence: 19
  givenname: Shusheng
  surname: Li
  fullname: Li, Shusheng
– sequence: 20
  givenname: Jianwei
  surname: Han
  fullname: Han, Jianwei
– sequence: 21
  givenname: Zhenliang
  surname: Li
  fullname: Li, Zhenliang
– sequence: 22
  givenname: Guolei
  surname: Ding
  fullname: Ding, Guolei
– sequence: 23
  givenname: Qun
  surname: Deng
  fullname: Deng, Qun
– sequence: 24
  givenname: Jicheng
  surname: Zhang
  fullname: Zhang, Jicheng
– sequence: 25
  givenname: Yue
  surname: Zhu
  fullname: Zhu, Yue
– sequence: 26
  givenname: Wenjing
  surname: Ma
  fullname: Ma, Wenjing
– sequence: 27
  givenname: Jingwen
  surname: Wang
  fullname: Wang, Jingwen
– sequence: 28
  givenname: Yan
  surname: Kang
  fullname: Kang, Yan
– sequence: 29
  givenname: Zhongheng
  orcidid: 0000-0002-2336-5323
  surname: Zhang
  fullname: Zhang, Zhongheng
BookMark eNp9Uklv1DAUjlARXeAPcIrEhUuKl9hxLkhVBXSkSlzgbHm8pB4Se7CdqtNfz5ulwFQI-WDrvW_xs7_z6iTEYKvqLUaXGAv-IWOKWNsgghtEuSBN96I6w5S3jWCUnfx1Pq3Oc14hhDvB6avqlLaEUULEWfW4CMbfezOr0T9aUyeb56x9UcXHUOeSVLHDpnYx1dmui9d1vov6x7YwHShLaPvgi60n_1DmBHs0dvRhqFUwtdkENQGvJKvKZEMBj8HD4XX10qkx2zeH_aL6_vnTt-ub5vbrl8X11W2jWYtKg_uO95TB1TE1qGtVKyznjgvO2g4zofmyx653VhGHW4cMM0hj0YuOoSWlll5Ui72uiWol18lPKm1kVF7uCjENUiWYbLQSqV4whrUjiLRcG_DgCCGBCNfCtT1ofdxrreflZI2GcZIaj0SPO8HfySHeS0E62vcYBN4fBFL8Odtc5OSztuOogo1zlgTsCUZ85_XuGXQV5xTgqbYo0vV9R8gf1KBgAB9cBF-9FZVXvCMUItByQF3-AwXLWPgbiJXzUD8ikD1Bp5hzsu73jBjJbfrkPn0S0id36ZMdkMQz0lOSwM2P_6P-Ah3y3q0
CitedBy_id crossref_primary_10_1007_s44231_022_00007_2
crossref_primary_10_3390_cells13050439
crossref_primary_10_17816_psaic1547
crossref_primary_10_3389_fmed_2021_809478
crossref_primary_10_3389_fmed_2023_1166896
crossref_primary_10_1186_s13613_025_01428_0
crossref_primary_10_4103_jtccm_JTCCM_D_21_00011
crossref_primary_10_3390_microorganisms11092165
crossref_primary_10_3389_fmed_2022_766447
crossref_primary_10_1038_s41746_023_00961_1
crossref_primary_10_1002_phar_2763
crossref_primary_10_1097_CCM_0000000000006100
crossref_primary_10_3390_medicina60111740
crossref_primary_10_4266_acc_000480
crossref_primary_10_1016_j_amjms_2024_11_010
crossref_primary_10_3389_fimmu_2025_1546474
crossref_primary_10_1097_MEJ_0000000000000893
crossref_primary_10_1155_2022_3893653
crossref_primary_10_1097_EC9_0000000000000033
crossref_primary_10_1186_s13054_022_04211_w
crossref_primary_10_15360_1813_9779_2024_6_2470
crossref_primary_10_15441_ceem_23_117
crossref_primary_10_1038_s41746_022_00580_2
crossref_primary_10_1097_CCE_0000000000001027
crossref_primary_10_1016_j_heliyon_2024_e28520
crossref_primary_10_4274_balkanmedj_galenos_2023_2023_4_6
crossref_primary_10_1016_j_isci_2022_105301
crossref_primary_10_1038_s41746_022_00650_5
crossref_primary_10_3389_fcvm_2023_1200441
crossref_primary_10_5005_jp_journals_10071_24546
crossref_primary_10_3389_fmed_2022_942356
Cites_doi 10.1097/EDE.0000000000000586
10.1016/j.jcrc.2019.11.004
10.1016/j.jcrc.2018.06.012
10.1186/s40560-020-00496-7
10.1186/s13054-016-1343-0
10.18637/jss.v061.i06
10.1186/s12887-018-1188-6
10.1097/01.CCM.0000298158.12101.41
10.1097/CCM.0000000000004476
10.1001/jama.2015.7885
10.1038/s41598-020-73014-2
10.1038/sdata.2018.178
10.1097/CCM.0000000000000520
10.1001/jama.2016.0287
10.7554/eLife.58142
10.1007/s00134-018-5367-6
10.3390/nu11122976
10.1016/j.jbi.2017.11.015
10.1093/bja/aeu300
10.1007/s12561-013-9097-6
10.1186/s13054-014-0532-y
10.1056/NEJMoa1500896
10.21037/atm.2019.06.75
10.1016/j.jcrc.2020.11.002
10.1186/s13054-020-03275-w
10.1111/biom.12306
10.21037/atm.2016.09.40
10.1002/emp2.12060
10.1038/s41591-018-0213-5
10.21037/atm.2017.09.39
10.1097/CCM.0b013e31825bc565
10.1186/s13054-018-2279-3
10.1007/s00134-012-2769-8
10.1097/CCM.0000000000003084
10.1097/CCM.0000000000004786
10.1097/CCM.0b013e31826ab377
10.1001/jama.2019.5791
10.18637/jss.v080.i02
10.1001/jama.2019.0071
10.1016/j.arcmed.2019.10.003
10.1080/01621459.2014.937488
10.1371/journal.pone.0168838
10.1145/2939672.2939785
10.1056/NEJMoa1401602
10.1111/jebm.12418
10.1056/NEJMoa1404380
10.1186/s12882-016-0323-6
10.1186/s13613-018-0402-x
10.1038/s41598-020-74906-z
10.1186/s13054-020-03204-x
10.1097/CCM.0000000000004610
10.1186/s13054-019-2411-z
ContentType Journal Article
Copyright COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021. The Author(s).
The Author(s) 2021
Copyright_xml – notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021. The Author(s).
– notice: The Author(s) 2021
DBID AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13054-021-03682-7
DatabaseName CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Proquest Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1364-8535
1366-609X
1466-609X
EndPage 16
ExternalDocumentID oai_doaj_org_article_0a98551cf20246cd86560008026c8f49
PMC8273991
A672336446
10_1186_s13054_021_03682_7
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: ;
  grantid: 81901929
– fundername: ;
  grantid: YLGX-ZZ-2020005
GroupedDBID ---
0R~
29F
2WC
4.4
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABUWG
ACGFS
ACJQM
ADBBV
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
E3Z
EBD
EBLON
EBS
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
OK1
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
ROL
RPM
RSV
SJN
SMD
SOJ
SV3
TR2
U2A
UKHRP
WOQ
YOC
PMFND
3V.
7XB
8FK
AZQEC
COVID
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c540t-197693517813d074a48e66f686547158c6b91f9fea2f14f0d5d0c1898750b33e3
IEDL.DBID 7X7
ISSN 1364-8535
1466-609X
IngestDate Wed Aug 27 01:27:43 EDT 2025
Thu Aug 21 18:04:39 EDT 2025
Fri Jul 11 03:08:07 EDT 2025
Fri Jul 25 05:21:08 EDT 2025
Tue Jun 17 21:29:47 EDT 2025
Tue Jun 10 20:38:14 EDT 2025
Thu Apr 24 23:10:05 EDT 2025
Tue Jul 01 03:55:01 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-197693517813d074a48e66f686547158c6b91f9fea2f14f0d5d0c1898750b33e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2336-5323
OpenAccessLink https://www.proquest.com/docview/2552799722?pq-origsite=%requestingapplication%
PMID 34253228
PQID 2552799722
PQPubID 44362
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_0a98551cf20246cd86560008026c8f49
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8273991
proquest_miscellaneous_2551210649
proquest_journals_2552799722
gale_infotracmisc_A672336446
gale_infotracacademiconefile_A672336446
crossref_primary_10_1186_s13054_021_03682_7
crossref_citationtrail_10_1186_s13054_021_03682_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-07-12
PublicationDateYYYYMMDD 2021-07-12
PublicationDate_xml – month: 07
  year: 2021
  text: 2021-07-12
  day: 12
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Critical care (London, England)
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References M Singer (3682_CR25) 2016; 315
DM Yealy (3682_CR2) 2014; 370
K Bouferrache (3682_CR7) 2012; 40
Z Zhang (3682_CR27) 2016; 4
SV Bhavani (3682_CR20) 2020; 48
LP Black (3682_CR54) 2020; 1
GA Ospina-Tascón (3682_CR3) 2019; 321
Z Zhang (3682_CR31) 2019; 7
SL Peake (3682_CR10) 2014; 371
B Gårdlund (3682_CR19) 2018; 47
KP Seitz (3682_CR45) 2020; 8
PR Mouncey (3682_CR11) 2015; 372
D Colon Hidalgo (3682_CR51) 2020; 55
Y-Q Zhao (3682_CR24) 2015; 110
MP Wallace (3682_CR39) 2017; 28
X Bai (3682_CR52) 2014; 18
3682_CR17
Y Liu (3682_CR32) 2017; 2017
MA Elbouhy (3682_CR55) 2019; 50
M Legrand (3682_CR9) 2016; 20
Z Zhang (3682_CR30) 2017; 5
W Alhazzani (3682_CR5) 2020; 44
TE Sweeney (3682_CR18) 2021; 49
M Jozwiak (3682_CR44) 2013; 41
ZA Puthucheary (3682_CR12) 2020; 24
J Waechter (3682_CR50) 2014; 42
MB Mayhew (3682_CR16) 2018; 78
CW Seymour (3682_CR1) 2015; 314
WY Kim (3682_CR13) 2019; 11
RP Dellinger (3682_CR4) 2008; 36
S Goradia (3682_CR26) 2021; 61
J Schulz (3682_CR34) 2020; 4
Z Zhang (3682_CR47) 2020; 13
TJ Pollard (3682_CR35) 2018; 5
F Díaz (3682_CR46) 2018; 18
Y Li (3682_CR53) 2020; 24
JK Barrett (3682_CR40) 2014; 6
MLNG Malbrain (3682_CR42) 2018; 8
3682_CR37
3682_CR36
Z Zhang (3682_CR23) 2020; 10
CW Seymour (3682_CR21) 2019; 321
MP Wallace (3682_CR33) 2017; 80
3682_CR6
Z Zhang (3682_CR14) 2018; 22
TE Sweeney (3682_CR15) 2018; 46
RJ Roberts (3682_CR49) 2020; 48
R Claure-Del Granado (3682_CR48) 2016; 17
EA Hoste (3682_CR43) 2014; 113
M Komorowski (3682_CR22) 2018; 24
Z Zhang (3682_CR8) 2019; 23
M Charrad (3682_CR29) 2014; 61
MP Wallace (3682_CR41) 2015; 71
3682_CR28
C Albert Vega (3682_CR38) 2020; 10
References_xml – volume: 28
  start-page: e18
  year: 2017
  ident: 3682_CR39
  publication-title: Epidemiology
  doi: 10.1097/EDE.0000000000000586
– volume: 55
  start-page: 145
  year: 2020
  ident: 3682_CR51
  publication-title: J Crit Care
  doi: 10.1016/j.jcrc.2019.11.004
– volume: 47
  start-page: 70
  year: 2018
  ident: 3682_CR19
  publication-title: J Crit Care
  doi: 10.1016/j.jcrc.2018.06.012
– volume: 8
  start-page: 78
  year: 2020
  ident: 3682_CR45
  publication-title: J Intensive Care
  doi: 10.1186/s40560-020-00496-7
– volume: 20
  start-page: 165
  year: 2016
  ident: 3682_CR9
  publication-title: Crit Care
  doi: 10.1186/s13054-016-1343-0
– volume: 61
  start-page: 1
  issue: 6
  year: 2014
  ident: 3682_CR29
  publication-title: J Stat Softw.
  doi: 10.18637/jss.v061.i06
– volume: 18
  start-page: 207
  year: 2018
  ident: 3682_CR46
  publication-title: BMC Pediatr
  doi: 10.1186/s12887-018-1188-6
– volume: 36
  start-page: 296
  year: 2008
  ident: 3682_CR4
  publication-title: Crit Care Med
  doi: 10.1097/01.CCM.0000298158.12101.41
– volume: 48
  start-page: 1445
  issue: 10
  year: 2020
  ident: 3682_CR49
  publication-title: Crit Care Med.
  doi: 10.1097/CCM.0000000000004476
– volume: 314
  start-page: 708
  year: 2015
  ident: 3682_CR1
  publication-title: JAMA
  doi: 10.1001/jama.2015.7885
– volume: 10
  start-page: 16136
  year: 2020
  ident: 3682_CR38
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-73014-2
– volume: 5
  start-page: 180178
  year: 2018
  ident: 3682_CR35
  publication-title: Sci Data
  doi: 10.1038/sdata.2018.178
– volume: 42
  start-page: 2158
  year: 2014
  ident: 3682_CR50
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0000000000000520
– volume: 315
  start-page: 801
  year: 2016
  ident: 3682_CR25
  publication-title: JAMA
  doi: 10.1001/jama.2016.0287
– ident: 3682_CR17
  doi: 10.7554/eLife.58142
– volume: 44
  start-page: 1691
  year: 2020
  ident: 3682_CR5
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-018-5367-6
– volume: 11
  start-page: 2976
  year: 2019
  ident: 3682_CR13
  publication-title: Nutrients
  doi: 10.3390/nu11122976
– volume: 78
  start-page: 33
  year: 2018
  ident: 3682_CR16
  publication-title: J Biomed Inform
  doi: 10.1016/j.jbi.2017.11.015
– volume: 113
  start-page: 740
  year: 2014
  ident: 3682_CR43
  publication-title: Br J Anaesth
  doi: 10.1093/bja/aeu300
– volume: 6
  start-page: 244
  year: 2014
  ident: 3682_CR40
  publication-title: Stat Biosci
  doi: 10.1007/s12561-013-9097-6
– volume: 18
  start-page: 1303
  year: 2014
  ident: 3682_CR52
  publication-title: Crit Care
  doi: 10.1186/s13054-014-0532-y
– volume: 372
  start-page: 1301
  year: 2015
  ident: 3682_CR11
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1500896
– volume: 7
  start-page: 345
  year: 2019
  ident: 3682_CR31
  publication-title: Ann Transl Med.
  doi: 10.21037/atm.2019.06.75
– volume: 61
  start-page: 233
  year: 2021
  ident: 3682_CR26
  publication-title: J Crit Care
  doi: 10.1016/j.jcrc.2020.11.002
– volume: 24
  start-page: 577
  year: 2020
  ident: 3682_CR12
  publication-title: Crit Care
  doi: 10.1186/s13054-020-03275-w
– volume: 71
  start-page: 636
  year: 2015
  ident: 3682_CR41
  publication-title: Biometrics
  doi: 10.1111/biom.12306
– volume: 4
  start-page: 9
  year: 2016
  ident: 3682_CR27
  publication-title: Ann Transl Med
  doi: 10.21037/atm.2016.09.40
– volume: 2017
  start-page: 380
  year: 2017
  ident: 3682_CR32
  publication-title: Healthc Inform
– volume: 1
  start-page: 222
  year: 2020
  ident: 3682_CR54
  publication-title: J Am Coll Emerg Physicians Open.
  doi: 10.1002/emp2.12060
– volume: 24
  start-page: 1716
  year: 2018
  ident: 3682_CR22
  publication-title: Nat Med
  doi: 10.1038/s41591-018-0213-5
– volume: 5
  start-page: 484
  year: 2017
  ident: 3682_CR30
  publication-title: Ann Transl Med
  doi: 10.21037/atm.2017.09.39
– volume: 40
  start-page: 2821
  year: 2012
  ident: 3682_CR7
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0b013e31825bc565
– volume: 22
  start-page: 347
  year: 2018
  ident: 3682_CR14
  publication-title: Crit Care
  doi: 10.1186/s13054-018-2279-3
– ident: 3682_CR6
  doi: 10.1007/s00134-012-2769-8
– volume: 46
  start-page: 915
  issue: 6
  year: 2018
  ident: 3682_CR15
  publication-title: Crit Care Med.
  doi: 10.1097/CCM.0000000000003084
– volume: 4
  start-page: 1
  year: 2020
  ident: 3682_CR34
  publication-title: J Am Stat Assoc
– volume: 49
  start-page: e170
  issue: 2
  year: 2021
  ident: 3682_CR18
  publication-title: Crit Care Med.
  doi: 10.1097/CCM.0000000000004786
– volume: 41
  start-page: 472
  year: 2013
  ident: 3682_CR44
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0b013e31826ab377
– volume: 321
  start-page: 2003
  year: 2019
  ident: 3682_CR21
  publication-title: JAMA
  doi: 10.1001/jama.2019.5791
– volume: 80
  start-page: 1
  issue: 2
  year: 2017
  ident: 3682_CR33
  publication-title: J Stat Softw.
  doi: 10.18637/jss.v080.i02
– volume: 321
  start-page: 654
  year: 2019
  ident: 3682_CR3
  publication-title: JAMA Am Med Assoc
  doi: 10.1001/jama.2019.0071
– ident: 3682_CR37
– volume: 50
  start-page: 325
  year: 2019
  ident: 3682_CR55
  publication-title: Arch Med Res
  doi: 10.1016/j.arcmed.2019.10.003
– volume: 110
  start-page: 583
  year: 2015
  ident: 3682_CR24
  publication-title: J Am Stat Assoc
  doi: 10.1080/01621459.2014.937488
– ident: 3682_CR28
  doi: 10.1371/journal.pone.0168838
– ident: 3682_CR36
  doi: 10.1145/2939672.2939785
– volume: 370
  start-page: 1683
  year: 2014
  ident: 3682_CR2
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1401602
– volume: 13
  start-page: 301
  year: 2020
  ident: 3682_CR47
  publication-title: J Evid Based Med
  doi: 10.1111/jebm.12418
– volume: 371
  start-page: 1496
  year: 2014
  ident: 3682_CR10
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1404380
– volume: 17
  start-page: 109
  year: 2016
  ident: 3682_CR48
  publication-title: BMC Nephrol
  doi: 10.1186/s12882-016-0323-6
– volume: 8
  start-page: 66
  year: 2018
  ident: 3682_CR42
  publication-title: Ann Intensive Care
  doi: 10.1186/s13613-018-0402-x
– volume: 10
  start-page: 17874
  year: 2020
  ident: 3682_CR23
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-74906-z
– volume: 24
  start-page: 488
  issue: 1
  year: 2020
  ident: 3682_CR53
  publication-title: Crit Care.
  doi: 10.1186/s13054-020-03204-x
– volume: 48
  start-page: 1645
  year: 2020
  ident: 3682_CR20
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0000000000004610
– volume: 23
  start-page: 1
  year: 2019
  ident: 3682_CR8
  publication-title: Crit Care
  doi: 10.1186/s13054-019-2411-z
SSID ssj0017863
Score 2.4800155
Snippet Background Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify...
Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of...
Abstract Background Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to...
SourceID doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 1
SubjectTerms Algorithms
Blood pressure
Care and treatment
Clinical medicine
Clinical trials
Creatinine
Critical care
Diagnosis
Dopamine
Dynamic treatment regime
Fluid resuscitation
Fluid therapy
Hospitals
Infections
Intervention
Laboratories
Machine learning
Methods
Mortality
Respiratory failure
Resuscitation
Sepsis
Septic shock
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS-UwEA-LB_Ei6rpYVyULgoelmDRtmh5VFHdBTwreQl4-8IHWZfseqH-9M0lb7Aq7l709XiaQZGYyv2nmg5BDIYJw4CbkjJmQl0ry3AgVQN0xjVGZhln8Dnl1LS9vy5931d27Vl8YE5bKA6eDO2amUWDVbQAvvZTWKawWEzNEpVWhjKl7YPMGZ6p_P6iVFEOKjJLHHdzUVZljOALc2IgpJ2YoVuv_eCf_GSf5zvBcbJD1HjHSk7TSTfLJt1tk9ap_E_9MXn-MOVXzV-8o-M9LsGvpiZ12qfrsCwVwSjsMYbG0u4dLkEa0mqbMYHiO4JM-zp_xSYHGBjlg1ahpHXWpaz0dg9IptnOAH9vk9uL85uwy7zsq5BaQ2SLnDbY-rOB4uHAAHkypvJRBKmxBzCtl5azhoQneFIGXgbnKMctVA04NmwnhxRey0j61fofQSroC2Msq4xVQMuOs8d5UxtUh2NJmhA8HrIc9Y9eLBx3dDiV1YooGpujIFF1n5Ps451cqtvFX6lPk20iJhbLjHyA-uhcf_S_xycgRcl2jOsPyrOmzEmCTWBhLn8i6EAJAo8zI3oQS1NBOhwe50f010OkC69thanKRkW_jMM7E0LbWPy0jDRZxk7iWeiJvk51NR9r5fSwFrgB9AsLf_R9H8ZWsFVFD6pwXe2Rl8Xvp9wFxLWYHUbneAMaYJv4
  priority: 102
  providerName: Directory of Open Access Journals
Title Individualized resuscitation strategy for septic shock formalized by finite mixture modeling and dynamic treatment regimen
URI https://www.proquest.com/docview/2552799722
https://www.proquest.com/docview/2551210649
https://pubmed.ncbi.nlm.nih.gov/PMC8273991
https://doaj.org/article/0a98551cf20246cd86560008026c8f49
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxQxFA7agvgiXnG0LhEEHyR0MslkMk_SlZYqtEixsPgSsrnYhTpbO7ug_fWek7noKPRlWTYn7GTOJd9JzoWQN0JE4cFNYHluI5NacWaFjqDumMaobZ07PIc8OVXH5_LTolz0B25tH1Y52MRkqP3a4Rn5foGlwjDLs3h_9YNh1yi8Xe1baNwlu1i6DKW6WowOF6906qTGhZIMtqVySJrRar8F211KhgEKYMMRZU42plS__38r_W_k5F9b0dFD8qDHkPSgY_ojcic0j8m9k_6W_Am5-ThmWa1ugqfgUW9hp-su3Wnb1aP9RQGu0haDWhxtL8As0oRfuylLGF4hHKXfVz_xkoGmljmwz1HbeOq7PvZ0DFOn2OABvjwl50eHXz4cs77HAnOA1TaM19gMsYRXxYUHOGGlDkpFpbEpMS-1U8uaxzoGW0QuY-5Lnzuua3Bz8qUQQTwjO826Cc8JLZUvgOF5aYMGytx6Z0OwpfVVjE66jPDhBZthzdgH49IkR0Qr0zHFAFNMYoqpMvJunHPVld-4lXqOfBspsXR2-mF9_c30mmhyW2uAiS4WAE-U8xrLD6WUY-V0lHVG3iLXDSo4PJ6zfZ4CLBJLZZkDVRUCJEqqjOxNKEEx3XR4kBvTG4bW_BHjjLweh3EmBrs1Yb1NNFjWTeGzVBN5m6xsOtKsLlJxcA14FDD_i9v__CW5XyTZrxgv9sjO5nobXgG62ixnSYVmZHd-ePr5bJbOKODzbP71N55gJdc
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLZKkYALYhUpBYwE4oCi2lkc54BQWaoZ2umpleZmPF7oSDTTNjOC6Y_iN_Kes0BA6q23UWxn4rzte_FbCHmVpj614CbEjGkfZ1LwWKfSg7hjGqPUJTP4HXJyKEbH2ZdpPt0gv7pcGAyr7HRiUNR2YfAb-U6CpcIwyzN5f3YeY9coPF3tWmg0bLHv1j_AZavfjT8BfV8nyd7no4-juO0qEBtAJ8uYl9j-L-eF5KkFA6oz6YTwQmIbXp5LI2Yl96V3OvE888zmlhkuwTfP2SxNXQr3vUFuguFl6OwV097Bg1uGzm08FVkMZjDvknSk2KnBVuRZjAERYDMQ1Q4MYegX8L9V-DdS8y_Tt3eP3G0xK91tmOw-2XDVA3Jr0p7KPySX4z6ra37pLAUPfgWWtTnkp3VT_3ZNAR7TGoNoDK1PQA3TgJebJTMYniP8pafzn3ioQUOLHrCrVFeW2nWlT2FdHxZPsaEE_HhEjq_l7T8mm9Wick8IzYVNgMFYrp2EmUxbo53TubaF9yYzEeHdC1bdnrHvxncVHB8pVEMUBURRgSiqiMjbfs1ZU-7jytkfkG79TCzVHS4sLr6pVvIV06UEWGp8AnBIGCux3FFIcRZG-qyMyBukukKFAo9ndJsXAZvE0lxqVxRJChyViYhsD2aCIjDD4Y5vVKuIavVHbCLysh_GlRhcV7nFKszBMnICn6UY8NtgZ8ORan4SipFLwL_gY2xd_ecvyO3R0eRAHYwP95-SO0mQgyLmyTbZXF6s3DNAdsvZ8yBOlHy9bvn9DRUAXHY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Individualized+resuscitation+strategy+for+septic+shock+formalized+by+finite+mixture+modeling+and+dynamic+treatment+regimen&rft.jtitle=Critical+care+%28London%2C+England%29&rft.au=Ma%2C+Penglin&rft.au=Liu%2C+Jingtao&rft.au=Shen%2C+Feng&rft.au=Liao%2C+Xuelian&rft.date=2021-07-12&rft.issn=1364-8535&rft.eissn=1364-8535&rft.volume=25&rft.issue=1&rft_id=info:doi/10.1186%2Fs13054-021-03682-7&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s13054_021_03682_7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1364-8535&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1364-8535&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1364-8535&client=summon